Freedom Biosciences
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $11M
Investors
- 4
About Freedom Biosciences
Based in California, US, and founded in 2021, Freedom Biosciences operates as a biotech company. The company was founded by its CEO Dina Burkitbayeva, CSO John Krystal, Hunter Bouchard, and Morgan Springer. Freedom Biosciences develops and offers FREE001, which is a ketamine treatment that is used for the treatment of major depressive illness. The company offers various ketamine and psychedelic-based treatments to patients suffering from mental health disorders.
Who invested in Freedom Biosciences
4 investors across 1 round
See all investors in Freedom Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 23, 2022
Amount
$11M
Investors
Questions about Freedom Biosciences
Who invested in Freedom Biosciences?
Freedom Biosciences has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Freedom Biosciences raised?
Freedom Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Freedom Biosciences last raise money?
Freedom Biosciences's most recent round on record is a Seed, in Aug 2022.
What does Freedom Biosciences do?
Based in California, US, and founded in 2021, Freedom Biosciences operates as a biotech company.
Where is Freedom Biosciences headquartered?
Freedom Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Freedom Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Freedom Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Freedom Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.